Navigation Links
High Blood Pressure Could Exacerbate Alzheimer's
Date:11/30/2007

Slowed blood flow to the brain may be to blame, MRI study shows

FRIDAY, Nov. 30 (HealthDay News) -- High blood pressure reduces blood flow to the brains of Alzheimer's patients and exacerbates the symptoms of the disease, a new study finds.

A team at the University of Pittsburgh used MRI to measure brain blood flow in older adults, including 20 Alzheimer's patients (10 with hypertension and 10 without); 48 normal adults (38 with hypertension and 10 without); and 20 people with mild cognitive impairment (10 with hypertension and 10 without).

Mild cognitive impairment affects brain functions such as language, attention and reasoning, and is a transition stage between normal age-related brain deficits and increased levels of dementia.

All the participants with hypertension showed substantially reduced blood flow in the brain. Alzheimer's patients with hypertension had the lowest levels of blood flow, but the normal adults with hypertension had significantly less blood flow than normal adults without high blood pressure.

"While hypertension is not a cause of Alzheimer's disease, our study shows that it is another hit on the brain that increases its vulnerability to the effects of the disease," study co-author Dr. Cyrus Raji, a Ph.D. candidate, said in a prepared statement.

"This study demonstrates that good vascular health is also good for the brain," added co-author Dr. Oscar Lopez, a professor of neurology and psychiatry. "Even in people with Alzheimer's disease, it is important to detect and aggressively treat hypertension and also to focus on disease prevention."

The findings were scheduled to be presented Wednesday in Chicago at the annual meeting of the Radiological Society of North America.

The results of this study follow a report earlier this month in Neurology in which researchers at Johns Hopkins University School of Medicine found that Alzheimer's may progress more rapidly in patients with high blood pressure and a heartbeat problem called atrial fibrillation.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.



-- Robert Preidt



SOURCE: Radiological Society of North America, news release, Nov. 28, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Specific antagonism lowers blood pressure
2. Restricting Blood Flow May Help Heart Bypass Patients
3. FDA Updates Prescription Guidelines for Blood Thinner
4. Doctors Often Miss High Blood Pressure in Kids
5. Back to School Means Return of School Blood Drives
6. Blood-flow detector software show promise in preventing brain damage
7. FDA Approves New Roche West Nile Virus Blood Screening Test
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Laser blasts viruses in blood
10. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
11. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/10/2016)... WASHINGTON, D.C. (PRWEB) , ... December 10, 2016 ... ... children’s Christmas wish lists for Santa are all sources of external stimuli that ... season. For some, the added pressure to spread holiday cheer through gifts, food ...
(Date:12/9/2016)... ... December 09, 2016 , ... ... aural rehabilitation—provided by audiologists—to remain a critical part of public access to hearing ... Administration (FDA) announced this week that, starting immediately, it would no ...
(Date:12/9/2016)... ... December 09, 2016 , ... The Justin Veatch Fund ... (NCADD) is recommending the film Whispering Spirits and its discussion guide for ... as an education tool in the war against teen drug abuse. NCADD is ...
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider of ... a new solution for Emergency Departments (ED) has been added to their portfolio. ... Department examination rooms, and with a simplified pallet of information available to the ...
(Date:12/8/2016)... ... 08, 2016 , ... After enjoying record-breaking attendance at its ... its 33rd Annual Issues & Research Conference, March 2-3, 2017, at the ... conference is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)... CITY , Dec. 8, 2016 ... US patents for improving the accuracy, reproducibility and ... images in long and small bone orthopaedic applications. ... approach to creating personalized orthopaedic restorations based on ... personalized orthopaedic restorations, the company harnesses the world,s ...
(Date:12/8/2016)... Mass. , Dec. 8, 2016  EIP ... it has obtained proof-of-mechanism for neflamapimod (previously code ... completed Phase 2a clinical trials that demonstrated significant ... Study 302 (12-week treatment) and Study 303 (6-week ... Clinical Trials in Alzheimer,s Disease (CTAD) scientific conference ...
Breaking Medicine Technology: